{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":null,"indication":null,"name":"CCTG BL12","nct_id":"NCT02033993","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=cctg-bl12-nct02033993. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Nab-Paclitaxel - 260mg/m2: q21 days","label":"Arm 1","type":"ACTIVE_COMPARATOR"},{"description":"Paclitaxel - 175mg/m2: q21 days","label":"Arm 2","type":"ACTIVE_COMPARATOR"}],"collaborators":["Australian and New Zealand Urogenital and Prostate Cancer Trials Group","Celgene"],"completion_date":{"date":"2020-10-28","type":"ACTUAL"},"conditions":["Urothelial Cancer"],"enrollment":{"count":199,"type":"ACTUAL"},"has_results":true,"interventions":[{"name":"Nab-Paclitaxel","otherNames":[],"type":"DRUG"},{"name":"Paclitaxel","otherNames":[],"type":"DRUG"}],"last_update":"2023-08-22","lead_sponsor":"Canadian Cancer Trials Group","official_title":"A Multicentre Randomized Phase II Trial Comparing Nab-Paclitaxel to Paclitaxel in Patients With Advanced Urothelial Cancer Progressing on or After a Platinum Containing Regimen.","overall_status":"COMPLETED","phases":["PHASE2"],"primary_completion_date":{"date":"2018-05-03","type":"ACTUAL"},"primary_outcomes":[{"measure":"Progression-Free Survival","timeFrame":"42 months"}],"references":[{"citation":"Sridhar SS, Blais N, Tran B, Reaume MN, North SA, Stockler MR, Chi KN, Fleshner NE, Liu G, Robinson JW, Mukherjee SD, Rahim Y, Winquist E, Booth CM, Nguyen NT, Beardsley EK, Alimohamed NS, McDonald GT, Ding K, Parulekar WR. Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial. JAMA Oncol. 2020 Nov 1;6(11):1751-1758. doi: 10.1001/jamaoncol.2020.3927.","pmid":"32940628","type":"RESULT"}],"start_date":{"date":"2014-03-11","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.","url":"https://clinicaltrials.gov/study/NCT02033993"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.1","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/cctg-bl12-nct02033993"}